where to inject igf-1 lr3 in Aesthetic and Anti-Aging Medicine: Benefits and Risks igf 1 lr3 where to

Who is eligible

Prominent features include epithelial barrier dysfunction, delayed or accelerated gastrointestinal transit due to abnormal function of smooth muscles, dysfunctional enteric nervous system and/or immunity, gut microbial dysbiosis, bile acid malabsorption, and alterations in the gut-brain axis (812)

Unlike most of the injectable peptides covered above, GHK-Cu has meaningful evidence for topical application its small enough to cross the stratum corneum and reach dermal fibroblasts at relevant concentrations

For general supplementation, quality reduced L-glutathione at 500 mg/day is a practical evidence-based starting point

A potent endogenous antioxidant, glutathione is essential for the liver's phase I and phase II detoxification